Home/Unravel Biosciences/Neal Muni, MD, MSPH

NM

Neal Muni, MD, MSPH

CMO

Unravel Biosciences

Therapeutic Areas

Neurology Rare Diseases Complex Disorders

Unravel Biosciences Pipeline

Drug	Indication	Phase
RVL-001 (vorinostat)	Rett Syndrome	Clinical Trial Initiated
New Chemical Entity	Rett Syndrome and other disorders	Pre-clinical

Leadership Team at Unravel Biosciences

Richard Novak, PhD

CEO & Co-Founder

Frederic Vigneault, PhD

CSO & Co-Founder

View full Unravel Biosciences profile